Valuation: Becton, Dickinson and Company

Market Cap 49.41B 42.87B 40.19B 36.61B 68.86B 4,710B 69.96B 474B 184B 2,359B 186B 181B 7,874B P/E 2026 *
37.5x
P/E 2027 * 22x
Enterprise Value 65.3B 56.65B 53.11B 48.38B 91B 6,224B 92.45B 626B 244B 3,117B 245B 240B 10,405B EV / Sales 2026 *
3.38x
EV / Sales 2027 * 3.21x
Free-Float
73.18%
Yield 2026 *
2.16%
Yield 2027 * 2.2%
1 day+1.20%
1 week+7.91%
Current month+10.84%
1 month+20.82%
3 months+28.24%
6 months+1.64%
Current year-5.41%
1 week 172.76
Extreme 172.76
183.75
1 month 148.34
Extreme 148.34
183.75
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
283.78
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Date Insider Type Main position Quantity % Market Cap.
8/6/26 Free

Director

189 0.0001%
8/6/26 Free

Director

94 0.0000%
7/27/26 Sell

Executive/Senior Manager

-75 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+1.20%+7.91%-4.63%-34.97% 49.41B
+1.08%+5.17%-15.57%+5.32% 190B
+0.09%+5.29%-2.14%+8.76% 116B
-5.90%+2.58%+8.07%+67.67% 63.71B
-0.91%+0.33%+34.28%+58.74% 55.13B
+1.42%+4.44%+16.63%-18.70% 33.79B
+1.31%-15.56% - - 30.74B
+0.26%+1.01%+46.59%-10.75% 24.73B
+0.89%+11.86%-5.01%+19.22% 23.85B
-0.68%+1.61%-2.08%+3.77% 23.23B
Average -0.31%+3.00%+8.46%+11.01% 61.05B
Weighted average by Cap. -0.59%+3.98%+0.89%+12.93%

Financials

2026 *2027 *
Net sales 19.29B 16.74B 15.69B 14.29B 26.88B 1,839B 27.31B 185B 72.02B 921B 72.43B 70.85B 3,074B 19.73B 17.12B 16.05B 14.62B 27.5B 1,881B 27.94B 189B 73.67B 942B 74.09B 72.47B 3,144B
Net income 1.36B 1.18B 1.11B 1.01B 1.9B 130B 1.93B 13.05B 5.09B 65.04B 5.11B 5B 217B 2.16B 1.87B 1.75B 1.6B 3.01B 206B 3.05B 20.67B 8.05B 103B 8.1B 7.92B 344B
Net Debt 15.88B 13.78B 12.92B 11.77B 22.14B 1,514B 22.49B 152B 59.3B 758B 59.64B 58.34B 2,531B 13.95B 12.1B 11.35B 10.34B 19.44B 1,330B 19.75B 134B 52.09B 666B 52.38B 51.24B 2,223B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-08-12 US$183.58 +1.20% 1,539,246
26-08-11 US$181.41 +0.99% 1,515,559
26-08-10 US$179.63 +1.57% 1,765,859
26-08-07 US$176.86 -0.12% 1,852,007
26-08-06 US$177.07 +3.76% 3,297,360
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
183.58USD
Average target price
193.25USD
Spread / Average Target
+5.27%

Quarterly revenue - Rate of surprise